Zobrazeno 1 - 10
of 86
pro vyhledávání: '"W. J. Catalona"'
Autor:
W. J. Catalona
Publikováno v:
JAMA: The Journal of the American Medical Association. 274:1214-1220
Autor:
G L, Andriole, W J, Catalona
Publikováno v:
Annual Review of Medicine. 45:351-359
▪ Abstract Over the last several years, the development of prostate-specific antigen (PSA) testing and technical refinements of anatomic radical prostatectomy have revolutionized the care of patients with prostate cancer. Serum PSA testing often al
Autor:
W. J. Catalona
Publikováno v:
JAMA: The Journal of the American Medical Association. 270:948-954
Autor:
W J, Catalona
Publikováno v:
Current Problems in Surgery. 27:395-461
Autor:
W. J. Catalona
Publikováno v:
Journal of Urology. 143:1068-1071
Publikováno v:
Cancer research. 61(13)
Two polymorphisms in the newly cloned prostate cancer susceptibility gene, HPC2/ELAC2, are suspected to be associated with an increased risk of developing the disease. These missense variants result in a serine (S) to leucine (L) substitution at amin
Publikováno v:
The Journal of urology. 165(4)
Scatter factor (SF), also known as hepatocyte growth factor (HGF), has been shown to induce proliferation, scattering and invasiveness in human prostate cancer cell lines. In this study we determined the serum level of SF-HGF in men with metastatic p
Autor:
B K, Suarez, J, Lin, J S, Witte, D V, Conti, M I, Resnick, E A, Klein, J K, Burmester, D A, Vaske, T K, Banerjee, W J, Catalona
Publikováno v:
The Prostate. 45(2)
Since the publication of the first genome screen for prostate cancer (CaP) 5 years ago, over a dozen linkage studies have appeared. Most attention has been directed to chromosome 1, where two separate regions have been identified as harboring a prost
Publikováno v:
Cancer. 89(6)
The importance of tumor size measurements as predictors of disease recurrence after radical prostatectomy in patients with prostate carcinoma remains somewhat controversial, and many pathologists do not report these measurements routinely. The author
Publikováno v:
Cancer research. 60(13)
Linkage to a prostate cancer susceptibility locus was recently reported on chromosome 16q23. We now report a region exhibiting a high frequency of allelic imbalance (AI) corresponding to this locus in tumors from 51 men diagnosed with prostate cancer